Continuous abdominal paracentesis for management of late type severe ovarian hyperstimulation syndrome

Journal of the Chinese Medical Association

Volumn 67, Issue 4, 2004, Pages 197-199

  Chan, Chying Chyuan ^a,b   Yin, Chang Sheng ^a,b   Lan, Shiu Chun ^a   Chen, I Ching ^b   Wu, Gwo Jang ^b  

^a Kang Ning General Hospital   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Continuous paracentesis; Euvolemia; OHSS

Indexed keywords

CHORIONIC GONADOTROPIN; LEUPRORELIN; RECOMBINANT FOLLITROPIN;

ABDOMINAL DRAINAGE; ABDOMINAL PAIN; ADULT; ARTICLE; ASCITES FLUID; BLOOD PRESSURE MEASUREMENT; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; EMBRYO; EMBRYO TRANSFER; ENDOMETRIOSIS; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; OVARY DISEASE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PARACENTESIS; PHYSICAL EXAMINATION; PLEURA EFFUSION;

ADULT; FEMALE; FERTILIZATION IN VITRO; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; PARACENTESIS; TREATMENT OUTCOME;

EID: 3042626631     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Levin I, Pharm B, Almog B, Avni A, Baram A, Lessing JB, et al. Effect of paracentesis of ascitic fluids urinary output and blood indices in patients with severe ovarian hyperstimulation syndrome. Fertil Steril 2002;77:986-8.
2. Chen CD, Yang JH, Chao KH, Chen SU, Ho HN, Yang YS, et al. Effects of repeated abdominal paracentesis on uterine and intraovarian haemodynamics and pregnancy outcome in severe ovarian hyperstimulation syndrome. Hum Reprod 1998; 13:2077-81.
3. Cremisi HD, Mitch WE. Profound hypotension and sodium retention with the ovarian hyperstimulation syndrome. Am J Kidney Dis 1994;24:854-7.
4. Schenker JG, Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil Steril 1978;31:255-68.
5. Joseph GW, Nikos FV. The ovarian hyperstimulation syndrome. Fertil Steril 2000;73:883-96.
6. Navot D, Relou A, Birkenfeld A, Rabinowitz R, Brzezinski A, Margalioth EJ, et al. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol 1988;259:210-5.
7. Enskog A, Henriksson M, Unander M, Nilsson L, Brannstrom M. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 1999;71:808-14.
8. Buyalos RP, Lee CT. Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization. Fertil Steril 1996;65:1-10.
9. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992;58:249-61.
10. Urman B, Pride SM, Yuen BH. Management of overstimulated gonadotrophin cycles with a controlled drift period. Hum Reprod 1992;7:213-7.
11. Queenan JT. Embryo freezing to prevent ovarian hyperstimulation syndrome. Mol Cell Endocrinol 2000;169:79-83.